Vera Therapeutics, Inc. (VERA) Institutional Ownership

Ownership Summary

A total of 173 institutions have reported a stake in Vera Therapeutics, Inc. (NASDAQ:VERA) as of September 2025, according to recent 13F filings with the SEC.

• These investors collectively held 102.0% of the company's total shares outstanding in September 2025, up from 100.8% in June 2025.
• In percentage terms, this reflects as a holdings change of 5.61% quarter on quarter, and an increase of 1.17% year over year.
• A review of institutional activity for Vera Therapeutics shows 91 of 173 filers increasing their positions, while 56 reduced their stake, and 26 remained unchanged.
• The total number of shares held by institutions in Vera Therapeutics increased to 65.13Mn as of September 2025, a net change of up by 3.46Mn shares quarter on quarter, and up 11.59Mn shares year over year.
• Avoro Capital Advisors LLC's holding of 6.21Mn shares as of September 30, 2025 makes it the primary institutional investor in Vera Therapeutics, owning 9.73% of the stock.
• Among the most significant buyers of Vera Therapeutics during September 2025 were CITADEL ADVISORS LLC (1.40Mn), Point72 Asset Management, L.P. (1.08Mn), Tri Locum Partners LP (777.09K), Pictet Asset Management Holding SA (666.31K), Kynam Capital Management, LP (600.91K).
• Leading sellers of Vera Therapeutics stock in September 2025 included Vestal Point Capital, LP (2.34Mn), MORGAN STANLEY (1.96Mn), Woodline Partners LP (1.87Mn), PRICE T ROWE ASSOCIATES INC /MD/ (813.28K), Affinity Asset Advisors, LLC (241.67K).
• The top 10 institutional holders of Vera Therapeutics for the quarter ending September 2025 included Avoro Capital Advisors LLC (6.21Mn), BlackRock, Inc. (4.25Mn), Kynam Capital Management, LP (4.03Mn), PRICE T ROWE ASSOCIATES INC /MD/ (3.67Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (3.64Mn), VANGUARD GROUP INC (3.19Mn), FMR LLC (2.84Mn), Eversept Partners, LP (2.81Mn), Sofinnova Investments, Inc. (2.79Mn), STATE STREET CORP (2.33Mn).